Search This Blog

Tuesday, February 16, 2021

United Therapeutics Target Up to 'Street High' at OPCO on Physician Survey Results

 Oppenheimer analyst Hartaj Singh raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to a 'Street High' $275.00

https://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+Street+High+%24275+at+Oppenheimer+Following+OPCO+Physician+Survey+Results/17973251.html

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)